Search for content, post, videos

He is the new CEO of SynAct Pharma

The company has announced the appointment of its current Chairman Torbjørn Bjerke as its new Chief Executive Officer, effective as from the Annual General Meeting to be held on May 25. Torbjørn Bjerke succeeds Jeppe Øvlesen, who will remain a committed shareholder of the company. The Nominatio
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.